Related Experiment Video
Updated: Jul 15, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Nanostructured materials for applications in drug delivery and tissue engineering
Michael Goldberg1, Robert Langer, Xinqiao Jia
1Department of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E25-342, Cambridge, MA 02139, USA.
Journal of Biomaterials Science. Polymer Edition
|May 3, 2007
Summary
Nanotechnology advances drug delivery and tissue engineering by creating nano-structured biomaterials. These materials offer improved drug release, cellular uptake, and tissue regeneration, overcoming limitations of current systems.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Regenerative Medicine
Background:
- Drug delivery and tissue engineering are rapidly advancing fields with significant potential for improving human health.
- Nanotechnology enables precise control over matter at the nanoscale, offering new possibilities for biomaterial design.
- Current limitations in drug delivery include poor bioavailability, targeting, and potential cytotoxicity, while tissue engineering scaffolds are evolving from macroporous materials to nano-scale topography mimicking the extracellular matrix.
Purpose of the Study:
- To review recent developments in nanostructured materials for drug delivery and tissue engineering.
- To highlight the role of nanotechnology in overcoming existing challenges in both fields.
- To emphasize the synergistic relationship between drug delivery and tissue engineering through nanostructured biomaterials.
Main Methods:
- Review of current literature on nanostructured materials in drug delivery and tissue engineering.
- Analysis of various nanocarrier systems (nanoparticles, nanocapsules, nanotubes, nanogels, dendrimers) for drug delivery.
- Examination of nanofibrous scaffolds and nanocomposites for tissue engineering applications, focusing on mimicking the natural extracellular matrix.
Main Results:
- Nanostructured biomaterials offer controlled composition, shape, size, and surface properties for enhanced drug delivery and cellular interactions.
- Nanoscale topography in tissue engineering scaffolds closely mimics the natural extracellular matrix, promoting better cell behavior and tissue formation.
- Nanocomposites, including those with nanocrystals, show promise in eliciting active bone growth.
- Tissue engineering can be conceptualized as a specialized form of drug delivery, focusing on controlled cell delivery.
Conclusions:
- Nanostructured materials are crucial for advancing both drug delivery and tissue engineering.
- Biomaterials designed at the nanometer scale can significantly enhance the biological functions of encapsulated drugs and cells.
- The integration of nanotechnology provides a versatile platform for developing next-generation therapeutic and regenerative strategies.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...